PaxMedica Inc. Common Sto... (PXMD)
OTC: PXMD
· Real-Time Price · USD
0.00
-0.00 (-100.00%)
At close: Mar 18, 2025, 2:54 PM
PaxMedica Common Stock Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -3M | -3.69M | -4.39M | -4.36M | -3.36M | -4.04M | -4.98M | -2.69M | -927.39K | -2M | -1.79M | -1.71M | -1.98M | -1.71M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -3M | -3.69M | -5.92M | -5.05M | -3.49M | -3.83M | -5.22M | -11.46M | 19.03K | 1.86M | 6.23M | -3.11M | -6.13M | -7.22M |
Net Income | -3M | -3.69M | -5.92M | -5.05M | -3.49M | -3.63M | -5.46M | -20.23M | 965.45K | 5.73M | 6.23M | -3.11M | -6.13M | -7.22M |
Selling & General & Admin | 1.49M | 3.3M | 3.22M | 2.43M | 2.77M | 3.81M | 4.74M | 2.37M | 775.96K | 933.82K | 1.32M | 1.28M | 1.09M | 1.29M |
Research & Development | 1.51M | 392.81K | 1.16M | 1.94M | 589.03K | 222.49K | 238.09K | 327.27K | 151.43K | 1.07M | 469.13K | 437.56K | 889.91K | 427.95K |
Other Expenses | n/a | -3.02K | -1.88M | -325.98K | -124.42K | 243.71K | -81.56K | -8.32M | 1.25M | 1.63M | 3.98M | -606.38K | -899.13K | -2.31M |
Operating Expenses | 3M | 3.69M | 4.39M | 4.36M | 3.36M | 4.04M | 4.98M | 2.69M | 927.39K | 2M | 1.79M | 1.71M | 1.98M | 1.71M |
Interest Expense | n/a | n/a | n/a | 1.31K | 3.93K | 3.93K | 3.93K | 1.31K | n/a | n/a | n/a | n/a | n/a | 2.81M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 3M | 3.69M | 4.39M | 4.36M | 3.36M | 4.04M | 4.98M | 2.69M | 927.39K | 2M | 1.79M | 1.71M | 1.98M | 1.71M |
Income Tax Expense | n/a | -46.3K | 193.76K | 1.31K | 3.93K | -199K | 239.18K | 8.77M | -946.42K | -3.87M | -8.02M | -660.38K | -954.93K | 2.81M |
Shares Outstanding (Basic) | 7.66M | 7.42M | 7.4M | 971.74K | 860.72K | 743.39K | 707.98K | 539.86K | 10.02M | 10.02M | 10.02M | 10.02M | 10.02M | 10.02M |
Shares Outstanding (Diluted) | 7.66M | 7.42M | 7.4M | 971.74K | 860.72K | 743.39K | 707.98K | 539.86K | 10.02M | 10.02M | 10.02M | 10.02M | 10.02M | 10.02M |
EPS (Basic) | -0.39 | -0.5 | -0.8 | -5.2 | -4.05 | -4.89 | -7.71 | -37.47 | 0.10 | 0.57 | 0.85 | -0.31 | -0.61 | -0.72 |
EPS (Diluted) | -0.39 | -0.5 | -0.8 | -5.2 | -4.05 | -4.89 | -7.71 | -37.47 | 0.10 | 0.57 | 0.85 | -0.31 | -0.61 | -0.72 |
EBITDA | -3M | -3.69M | -4.39M | -4.36M | -3.48M | -4.04M | -4.98M | -2.69M | 19.03K | -370.3K | 6.23M | -2.32M | -2.88M | -4.02M |
EBIT | -3M | -3.69M | -5.92M | -5.05M | -3.48M | -3.83M | -5.22M | -11.46M | 19.03K | 1.86M | 6.23M | -3.11M | -6.13M | -4.41M |
Depreciation & Amortization | 729.00 | 43.28K | 43.81K | -325.98K | -124.42K | 243.71K | -81.56K | -8.41M | 949.58K | 1.63M | 8.02M | -606.38K | -899.13K | -2.31M |